Skip to main content
Veterinary Medicines

Giraxa, 50mg/g, Powder for oral solution

Authorised
  • COLISTIN SULFATE

Product identification

Medicine name:
Giraxa, 50mg/g, Powder for oral solution
Giraxa 50 mg /g pulveris iekšķīgi lietojama šķīduma pagatavošanai teļiem, sivēniem un vistām
Active substance:
  • COLISTIN SULFATE
Target species:
  • Chicken (broiler)
  • Cattle (calf)
  • Pig (piglet)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    50.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • Meat and offal
        1
        day
      • Egg
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        1
        day
    • Pig (piglet)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/08/1563
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0103/001
Concerned member states:
  • Latvia
  • Lithuania
  • Poland
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."